Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05564936 · ClinicalTrials.gov registry record · NA
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
A NA study of Myasthenia Gravis, sponsored by Ad scientiam.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 19
- Study locations
NCT05564936 is a NA study of Myasthenia Gravis that is actively recruiting participants, run by Ad scientiam. The registered enrollment target is 144 participants, below the 187-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (23% lower). The trial reports 19 study locations across 10 states.
The verdict
NCT05564936, a NA study of Myasthenia Gravis, is actively recruiting participants, sponsored by Ad scientiam.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 19
- Study locations
Study Summary
ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG. ME\&MG contains digital active tests for the assessment of ptosis, breathing, dysarthria, upper- and lower-limb (arms and legs) weakness, treatment follow-up, and validated e-questionnaires related to daily activities, pain, fatigue, sleep, and depression disorders. The objectives of this study are to validate the accuracy, reliability and reproducibility of the unsupervised at-home self-assessment of symptoms on the patient's smartphone with ME\&MG versus the standard in-clinic testing, as well as to evaluate the safety of the solution, its usability and satisfaction.
Conditions Studied
Interventions
- DEVICE ME&MG mobile application
Study Locations (19)
Other
- Hôpital Raymond Poincaré - Garches
- CHU Grenoble - Grenoble
- Hôpital Salengro - Lille
- CHRU Nancy - Nancy
- CHU Nantes - Nantes
- Pitié-Salpêtrière - Paris
- CHU de Strasbourg - Hôpital de Hautepierre - Strasbourg
- CHU Toulouse - Toulouse
Indiana
- HealthParterns Institute - Bloomington
- Indiana University Health - Indianapolis
Tennessee
- The University of Tennessee Medical Center - Knoxville
- Vanderbilt Health - Nashville
Colorado
- University of Colorado Denver - Aurora
Florida
- University of Florida Health - Jacksonville
Kentucky
- University of Kentucky - Lexington
New York
- Neurological Associates of Long Island, P.C. - Lake Success
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2026-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05564936
The ClinicalTrials.gov registry entry for NCT05564936 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 187-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (23% lower). The listed sponsor is Ad scientiam, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which ME&MG mobile application is the first listed.
NCT05564936 reports 19 study locations spanning 10 distinct geographic areas - top geographies include Other, Indiana, Tennessee.
Frequently Asked Questions
What is clinical trial NCT05564936 about?
NCT05564936 is a clinical study titled "The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis". ME\&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians. It is intended to be used as an unsupervised digital self-assessment tool for the monitoring of disabilities in patients living with MG. ME\&MG contains digital active tests...
What is the current status of trial NCT05564936?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2024-01-24. Estimated completion is 2026-09-24.
What conditions does trial NCT05564936 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
What interventions are being tested in trial NCT05564936?
The interventions under investigation include: ME&MG mobile application (DEVICE).
Who is sponsoring clinical trial NCT05564936?
This trial is sponsored by Ad scientiam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05564936 being conducted?
This trial has 19 study locations across Colorado, Florida, Indiana, Kentucky, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
-
SP Thoracic IDE Study
ACTIVE NOT RECRUITING · NA
-
Clinical Trial to Improve the Magnetic Levator Prosthesis
COMPLETED · NA
-
Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis
COMPLETED · NA
-
Acupuncture in Myasthenia Gravis (AcuMG)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.